419 related articles for article (PubMed ID: 32008730)
21. Progestogens and pregnancy loss.
Carp HJA
Climacteric; 2018 Aug; 21(4):380-384. PubMed ID: 29565684
[TBL] [Abstract][Full Text] [Related]
22. Peri-conceptional progesterone treatment in women with unexplained recurrent miscarriage: a randomized double-blind placebo-controlled trial.
Ismail AM; Abbas AM; Ali MK; Amin AF
J Matern Fetal Neonatal Med; 2018 Feb; 31(3):388-394. PubMed ID: 28114846
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of progesterone on threatened miscarriage: an updated meta-analysis of randomized trials.
Yan Y; Chen Z; Yang Y; Zheng X; Zou M; Cheng G; Yuan Z
Arch Gynecol Obstet; 2021 Jan; 303(1):27-36. PubMed ID: 32989508
[TBL] [Abstract][Full Text] [Related]
24. Progestogen for treating threatened miscarriage.
Wahabi HA; Abed Althagafi NF; Elawad M; Al Zeidan RA
Cochrane Database Syst Rev; 2011 Mar; (3):CD005943. PubMed ID: 21412891
[TBL] [Abstract][Full Text] [Related]
25. Progestogen for treating threatened miscarriage.
Wahabi HA; Fayed AA; Esmaeil SA; Al Zeidan RA
Cochrane Database Syst Rev; 2011 Dec; (12):CD005943. PubMed ID: 22161393
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis.
Wu H; Zhang S; Lin X; He J; Wang S; Zhou P
Reprod Biol Endocrinol; 2021 Nov; 19(1):165. PubMed ID: 34732210
[TBL] [Abstract][Full Text] [Related]
27. Luteal start vaginal micronized progesterone improves pregnancy success in women with recurrent pregnancy loss.
Stephenson MD; McQueen D; Winter M; Kliman HJ
Fertil Steril; 2017 Mar; 107(3):684-690.e2. PubMed ID: 28081870
[TBL] [Abstract][Full Text] [Related]
28. Progestogen for treating threatened miscarriage.
Wahabi HA; Abed Althagafi NF; Elawad M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005943. PubMed ID: 17636813
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of progesterone on threatened miscarriage: Difference in drug types.
Wang XX; Luo Q; Bai WP
J Obstet Gynaecol Res; 2019 Apr; 45(4):794-802. PubMed ID: 30632226
[TBL] [Abstract][Full Text] [Related]
30. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
[TBL] [Abstract][Full Text] [Related]
31. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H; Sukhikh GT; Kahler E; Griesinger G
Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
[TBL] [Abstract][Full Text] [Related]
32. Treatment options for threatened miscarriage.
Qureshi NS
Maturitas; 2009 Dec; 65 Suppl 1():S35-41. PubMed ID: 19945236
[TBL] [Abstract][Full Text] [Related]
33. [Effectiveness of progesterone in pregnancy complications].
van der Hoorn MP; Lashley EELO
Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31682091
[TBL] [Abstract][Full Text] [Related]
34. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
[TBL] [Abstract][Full Text] [Related]
35. Does first trimester progesterone prophylaxis increase the live birth rate in women with unexplained recurrent miscarriages?
Coomarasamy A; Truchanowicz EG; Rai R
BMJ; 2011 Apr; 342():d1914. PubMed ID: 21502263
[No Abstract] [Full Text] [Related]
36. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial.
Clifford K; Rai R; Watson H; Franks S; Regan L
BMJ; 1996 Jun; 312(7045):1508-11. PubMed ID: 8646142
[TBL] [Abstract][Full Text] [Related]
37. Did the NICE guideline for progesterone treatment of threatened miscarriage get it right?
Duncan WC
Reprod Fertil; 2022 Apr; 3(2):C4-C6. PubMed ID: 35514538
[TBL] [Abstract][Full Text] [Related]
38. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
39. Double-blind randomized trial of progesterone to prevent preterm birth in second-trimester bleeding.
Salim R; Hakim M; Zafran N; Nachum Z; Romano S; Garmi G
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1318-1325. PubMed ID: 31087325
[TBL] [Abstract][Full Text] [Related]
40. Uteroplacental circulation in early pregnancy complicated by threatened abortion supplemented with vaginal micronized progesterone or oral dydrogesterone.
Czajkowski K; Sienko J; Mogilinski M; Bros M; Szczecina R; Czajkowska A
Fertil Steril; 2007 Mar; 87(3):613-8. PubMed ID: 17126337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
